SCHEMBL4062291

SCHEMBL4062291

Cc1c(C(=O)NN)cccc1N1CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 2/20 0.55
HTR6 P50406 7/20 0.46
HTR1A P08908 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
HTR3A P46098 2/20 0.46
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
DRD3 P35462 1/20 0.46
ALDH1A1 P00352 1/20 0.43
MT-CO2 P00403 1/20 0.42
HTR7 P34969 1/20 0.42
BACE1 P56817 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3951660 0.84 ADRB1 (0.59) ADRB1HTR6HTR1ACYP1A2CYP3A4
SCHEMBL1742844 0.84 ADRB1 (0.59) ADRB1HTR6HTR1ACYP1A2CYP3A4
SCHEMBL4062286 0.81 ADRB1 (0.44) ADRB1HTR1ACYP1A2CYP3A4CYP2D6
SCHEMBL5864197 0.80 ADRB1 (0.54) ADRB1HTR6HTR1ACYP1A2CYP3A4
SCHEMBL1742847 0.74 ADRB1 (0.51) ADRB1HTR6HTR1ACYP1A2CYP2D6
SCHEMBL9283305 0.73 OPRD1 (0.50) ADRB1HTR6HTR1AHTR3ADRD2
SCHEMBL13563351 0.73 HTR1A (0.69) ADRB1HTR6HTR1ACYP1A2CYP3A4
SCHEMBL27654677 0.73 HTR1A (0.47) ADRB1HTR6HTR1ACYP1A2CYP3A4
SCHEMBL3626941 0.72 ADRB1 (0.69) ADRB1HTR6HTR1ACYP1A2CYP3A4
SCHEMBL9283309 0.72 DRD2 (0.52) ADRB1HTR6HTR1ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2077841-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited (GB) 2009-07-15 EP claimed
WO-2008052934-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2008-05-08 WO claimed
EP-2077841-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS Glaxo Group Limited (GB) 2009-07-15 EP disclosed
WO-2008052934-A1 NOVEL SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2008-05-08 WO disclosed
WO-2006027211-A1 2,4-SUBSTITUTED PYRIMIDINES AS CYSTEINE PROTEASE INHIBITORS GLAXO GROUP LIMITED (GB) 2006-03-16 WO disclosed